Airnexis Therapeutics, Inc.

This early-stage study is testing a new inhaled medicine called AN01 in 24 healthy adults to see if it is safe and how the body processes it. AN01 is being developed as a possible treatment for COPD, a lung disease that makes breathing hard. The study does not involve people with…